An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
Clinical trial NCT06503224 · RECRUITING
Trial details
- NCT number
- NCT06503224
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-09
- Primary completion
- 2026-04-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.